Your browser doesn't support javascript.
loading
Lobeglitazone and pioglitazone as add-ons to metformin for patients with type 2 diabetes: a 24-week, multicentre, randomized, double-blind, parallel-group, active-controlled, phase III clinical trial with a 28-week extension.
Jin, S-M; Park, C-Y; Cho, Y M; Ku, B J; Ahn, C W; Cha, B-S; Min, K W; Sung, Y A; Baik, S H; Lee, K W; Yoon, K-H; Lee, M-K; Park, S W.
Afiliación
  • Jin SM; Division of Endocrinology and Metabolism, Department of Medicine, Samsung Medical Centre, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
  • Park CY; Department of Endocrinology and Metabolism, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
  • Cho YM; Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea.
  • Ku BJ; Department of Internal Medicine, School of Medicine, Chungnam National University, Daejeon, Republic of Korea.
  • Ahn CW; Department of Internal Medicine, Gangnam Severance Hospital, Yonsei University of College of Medicine, Seoul, Republic of Korea.
  • Cha BS; Department of Internal Medicine, Severance Hospital, Yonsei University of Collage of Medicine, Seoul, Republic of Korea.
  • Min KW; Diabetes Centre, Department of Endocrinology and Metabolism, Eulji General Hospital, Eulji University School of Medicine, Seoul, Republic of Korea.
  • Sung YA; Department of Internal Medicine, EwhaWomans University School of Medicine, Seoul, Republic of Korea.
  • Baik SH; Division of Endocrinology and Metabolism, Department of Internal Medicine, College of Medicine, Korea University, Seoul, Republic of Korea.
  • Lee KW; Department of Endocrinology and Metabolism, Ajou University School of Medicine, Suwon, Republic of Korea.
  • Yoon KH; Department of Endocrinology and Metabolism, Immunology, Cell Biology Core Laboratory, Institutes of Medical Science, The Catholic University of Korea, Seoul, Republic of Korea.
  • Lee MK; Division of Endocrinology and Metabolism, Department of Medicine, Samsung Medical Centre, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
  • Park SW; Department of Endocrinology and Metabolism, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
Diabetes Obes Metab ; 17(6): 599-602, 2015 Jun.
Article en En | MEDLINE | ID: mdl-25580775
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Pirimidinas / Tiazolidinedionas / Diabetes Mellitus Tipo 2 / Hipoglucemiantes / Metformina Tipo de estudio: Clinical_trials Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Año: 2015 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Pirimidinas / Tiazolidinedionas / Diabetes Mellitus Tipo 2 / Hipoglucemiantes / Metformina Tipo de estudio: Clinical_trials Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Año: 2015 Tipo del documento: Article